サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629317

胃内滞留性ドラッグデリバリーシステムのアウトソーシングの世界市場：薬剤の種類別・剤形別・サービスの種類別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Gastroretentive Drug Delivery Systems Outsourcing Market, By Drug Type, By Dosage Form, By Service Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
胃内滞留性ドラッグデリバリーシステムのアウトソーシングの世界市場：薬剤の種類別・剤形別・サービスの種類別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

胃内滞留性ドラッグデリバリーシステムのアウトソーシングの市場規模は2023年に14億9,054万米ドルとなり、2024年から2032年にかけてCAGR 7.20%で拡大

胃内滞留性ドラッグデリバリーシステムのアウトソーシングの市場力学

慢性疾患の蔓延が胃内滞留性ドラッグデリバリーシステムのアウトソーシングの需要を押し上げる

WHOによると、糖尿病や高血圧などの慢性疾患の負担が増加し、世界全体で15億人以上に影響が及んでいることから、胃内滞留性システムのような革新的なドラッグデリバリーソリューションに対する需要が高まっています。これらのシステムは、薬物を長時間放出し、治療成績と患者のアドヒアランスを向上させます。製薬会社は、運用コストを削減し、複雑な規制要件を満たすために、こうしたシステムの開発・製造を外注するケースが増えています。例えば、米国FDAは薬効を高めるための放出制御技術の重要性を強調し、メーカーに技術革新を促しています。さらに、アウトソーシングを利用することで、浮遊性薬剤や生体接着性薬剤技術に関する専門知識を利用することができます。インドやブラジルのように医療インフラが拡大している新興国では、費用対効果の高いアウトソーシング・ソリューションの機会があり、企業は標的薬物送達システムに対する需要の高まりに効率的に対応することができます。

胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：主な考察

弊社のリサーチアナリストの分析によると、世界市場は予測期間 (2024-2032年) に約7.20%のCAGRで毎年成長すると予測されています。

薬剤の種類別では、抗生物質が2023年に最大の市場シェアを示すと予測されています。

剤形別では、錠剤が2023年の主要セグメントです。

サービスの種類別では、製剤開発が2023年の主要セグメントでした。

地域別では、北米が2023年の主要収益源であった

胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：セグメンテーション分析

胃内滞留性ドラッグデリバリーシステムのアウトソーシングの世界市場は、薬剤の種類、剤形、サービスの種類、エンドユーザー、地域に基づいて区分されます。

市場は薬剤の種類に基づいて4つのカテゴリーに分けられます：抗糖尿病薬、抗生物質、プロトンポンプ阻害薬、制吐薬です。抗生物質は感染症の治療に広く使用されているため圧倒的なシェアを占めており、次いでプロトンポンプ阻害薬が消化器疾患の管理に使用されています。次に糖尿病治療薬が、糖尿病患者数の増加に牽引される形でランクインし、制吐薬は吐き気管理というニッチな用途のため優先順位は最下位です。

市場は剤形によって4つのカテゴリーに分けられます：錠剤、カプセル、懸濁剤、粉末です。錠剤の優先順位は、製剤化の容易さと患者のコンプライアンスにより最も高く、次いで放出制御特性を持つカプセル剤です。次いで、小児用や老人用の懸濁液が優先され、粉末は優先順位が低く、主に特殊な症例で使用されます。

胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：地域別分析

胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場は、医療インフラと医薬品イノベーションの影響を受けた明確な地理的動向を示しています。北米は、高度な医薬品開発能力、確立された製薬業界、FDAによる支援的な規制枠組みにより市場をリードしています。欧州は、ドラッグデリバリー技術への投資の増加や、慢性疾患管理を必要とする高齢化によって、僅差で続いています。アジア太平洋地域では、インドや中国のような国々が、コスト効率の高い製造、熟練した労働力、拡大する医療部門に後押しされ、有力なアウトソーシング拠点として台頭してきています。例えば、インドの医薬品輸出は2023年に250億米ドルを超え、その重要性が高まっていることを物語っています。ラテンアメリカと中東・アフリカは、医療へのアクセスが拡大し、現地の医薬品産業を振興するイニシアチブがあるため、緩やかな成長を示しています。しかし、一部の発展途上地域では、コストの制約や限られた技術的専門知識が普及の課題となっています。

胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：競合情勢

胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場は競争が激しく、世界および地域のプレーヤーが技術革新、戦略的パートナーシップ、規制基準の遵守に注力しています。Lonza Group、Catalent Inc、Recipharm ABなどの新興国企業は、製剤開発や製造を含む包括的なアウトソーシング・サービスを提供することで市場を独占しています。これらの企業は研究開発に多額の投資を行い、浮遊性、生体接着性、膨潤性システムなどの高度な胃内滞留性技術を自社のポートフォリオに組み込んでいます。特にアジア太平洋地域の新興企業は、コスト効率の高い生産と特殊なドラッグデリバリーソリューションに対する需要の高まりを活用しています。製薬企業との共同開発によるオーダーメイドのシステム開発やサービス・ポートフォリオの拡充は、一般的な戦略です。例えば、慢性疾患管理用の生体接着システムの開発におけるパートナーシップが勢いを増しています。また、持続可能な製造方法への関心の高まりは、市場参入企業間の競争をさらに激化させています。

目次

第1章 胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 胃内滞留性ドラッグデリバリーシステムのアウトソーシングの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 胃内滞留性ドラッグデリバリーシステムのアウトソーシングの市場情勢

  • 胃内滞留性ドラッグデリバリーシステムのアウトソーシングの市場シェア分析 (2023年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：薬物の種類別

  • 概要
    • セグメント別シェア分析：薬物の種類別
    • 抗糖尿病薬
    • 抗生物質
    • プロトンポンプ阻害剤
    • 制吐剤

第8章 胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：剤形別

  • 概要
    • セグメント別シェア分析：剤形別
    • 錠剤
    • カプセル
    • 懸濁剤
    • 粉末

第9章 胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：サービスの種類別

  • 概要
    • セグメント別シェア分析：サービスの種類別
    • 処方開発
    • 分析試験
    • 臨床試験管理
    • 医薬品製造

第10章 胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 製薬会社
    • バイオテクノロジー企業
    • CRO
    • CMO (最高マーケティング責任者)

第11章 胃内滞留性ドラッグデリバリーシステムのアウトソーシング市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・フリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：胃内滞留性ドラッグデリバリーシステムのアウトソーシング業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Ajinomoto Bio-Pharma Services
    • Alcami Corporation
    • Boehringer Ingelheim International GmbH
    • Catalent, Inc.
    • Charles River Laboratories
    • Evonik Industries AG
    • Famar SA
    • Jubilant Pharmova Limited
    • Lonza Group AG
    • Patheon NV
    • Piramal Pharma Solutions
    • Recipharm AB
    • Syngene International Limited
    • Thermo Fisher Scientific Inc.
    • Vetter Pharma International GmbH
    • WuXi AppTec Co., Ltd.
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4478

REPORT HIGHLIGHT

The Gastroretentive Drug Delivery Systems Outsourcing Market size was valued at USD 1,490.54 million in 2023, expanding at a CAGR of 7.20% from 2024 to 2032.

The Gastroretentive Drug Delivery Systems Outsourcing Market focuses on outsourcing services related to drug delivery systems designed to remain in the stomach for extended periods, ensuring controlled and targeted drug release. The rising prevalence of gastrointestinal disorders and chronic conditions like diabetes and hypertension, which collectively affect over 1.5 billion people globally, has created a significant demand for advanced drug delivery mechanisms. Pharmaceutical companies increasingly rely on outsourcing for cost-efficiency, access to specialized expertise, and adherence to stringent regulatory standards. However, challenges such as high development costs and complexities in maintaining quality compliance restrain market growth. On the other hand, technological advancements, such as floating and bioadhesive drug delivery systems, along with expanding healthcare infrastructure in emerging economies, present lucrative opportunities for service providers to enhance their offerings.

Gastroretentive Drug Delivery Systems Outsourcing Market- Market Dynamics

Expanding Prevalence of Chronic Diseases Boosts Demand for Gastroretentive Drug Delivery Systems Outsourcing

The rising burden of chronic diseases such as diabetes and hypertension, which together impact over 1.5 billion individuals globally according to the WHO, has driven demand for innovative drug delivery solutions like gastroretentive systems. These systems ensure prolonged drug release, improving therapeutic outcomes and patient adherence. Pharmaceutical companies increasingly outsource the development and manufacturing of these systems to reduce operational costs and meet complex regulatory requirements. For instance, the U.S. FDA emphasizes the importance of controlled-release technologies to enhance drug efficacy, pushing manufacturers to innovate. Additionally, outsourcing provides access to specialized expertise in floating and bioadhesive drug technologies. Emerging economies with expanding healthcare infrastructure, like India and Brazil, offer opportunities for cost-effective outsourcing solutions, enabling companies to cater to the growing demand for targeted drug delivery systems efficiently.

Gastroretentive Drug Delivery Systems Outsourcing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.20% over the forecast period (2024-2032)

Based on Drug Type segmentation, Antibiotics was predicted to show maximum market share in the year 2023

Based on Dosage Form segmentation, Tablets was the leading segment in 2023

Based on Service Type segmentation, Formulation Development was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Gastroretentive Drug Delivery Systems Outsourcing Market- Segmentation Analysis:

The Global Gastroretentive Drug Delivery Systems Outsourcing Market is segmented on the basis of Drug Type, Dosage Form, Service Type, End-User, and Region.

The market is divided into four categories based on Drug Type: Antidiabetics, Antibiotics, Proton Pump Inhibitors, and Antiemetics. Antibiotics dominate due to widespread use in treating infections, followed by proton pump inhibitors for managing gastrointestinal conditions. Antidiabetics rank next, driven by rising diabetes prevalence, while antiemetics hold the lowest priority for their niche application in nausea management.

The market is divided into four categories based on Dosage Form: Tablets, Capsules, Suspensions, and Powders. Tablets hold the highest priority due to ease of formulation and patient compliance, followed by capsules for their controlled-release properties. Suspensions rank next, preferred for pediatric and geriatric use, while powders are least prioritized, used primarily in specialized cases.

Gastroretentive Drug Delivery Systems Outsourcing Market- Geographical Insights

The Gastroretentive Drug Delivery Systems Outsourcing Market shows distinct geographical trends influenced by healthcare infrastructure and pharmaceutical innovation. North America leads the market due to advanced drug development capabilities, well-established pharmaceutical industries, and supportive regulatory frameworks by the FDA. Europe follows closely, driven by rising investments in drug delivery technologies and an aging population requiring chronic disease management. In Asia-Pacific, countries like India and China are emerging as prominent outsourcing hubs, fueled by cost-effective manufacturing, skilled labor, and expanding healthcare sectors. For instance, India's pharmaceutical exports crossed $25 billion in 2023, showcasing its growing prominence. Latin America and the Middle East & Africa exhibit moderate growth due to increasing healthcare access and initiatives to promote local pharmaceutical industries. However, cost constraints and limited technical expertise in some developing regions pose challenges to widespread adoption.

Gastroretentive Drug Delivery Systems Outsourcing Market- Competitive Landscape:

The Gastroretentive Drug Delivery Systems Outsourcing Market is highly competitive, with global and regional players focusing on technological innovation, strategic partnerships, and compliance with regulatory standards. Leading companies like Lonza Group, Catalent Inc., and Recipharm AB dominate the market by offering comprehensive outsourcing services, including formulation development and manufacturing. These players invest heavily in R&D to integrate advanced gastroretentive technologies, such as floating, bioadhesive, and swelling systems, into their portfolios. Emerging firms, particularly in Asia-Pacific, capitalize on cost-effective production and growing demand for specialized drug delivery solutions. Collaborations with pharmaceutical companies to develop tailored systems and expand service portfolios are common strategies. For instance, partnerships in the development of bioadhesive systems for chronic disease management have gained momentum. Additionally, increasing interest in sustainable manufacturing practices further intensifies competition among market participants.

Recent Developments:

In August 2022, Catalent announced its acquisition of Metrics Contract Services for USD 475 million to enhance its oral development and manufacturing capabilities. This acquisition aims to strengthen Catalent's expertise in integrated oral solid formulation, research, production, and packaging.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Ajinomoto Bio-Pharma Services
  • Alcami Corporation
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Charles River Laboratories
  • Evonik Industries AG
  • Famar SA
  • Jubilant Pharmova Limited
  • Lonza Group AG
  • Patheon N.V.
  • Piramal Pharma Solutions
  • Recipharm AB
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • Vetter Pharma International GmbH
  • WuXi AppTec Co., Ltd.
  • Others

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antidiabetics
  • Antibiotics
  • Proton Pump Inhibitors
  • Antiemetics

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Tablets
  • Capsules
  • Suspensions
  • Powders

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Formulation Development
  • Analytical Testing
  • Clinical Trials Management
  • Drug Manufacturing

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotech Companies
  • CROs
  • CMO

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Gastroretentive Drug Delivery Systems Outsourcing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Drug Type
    • 2.1.2. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Dosage Form
    • 2.1.3. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Service Type
    • 2.1.4. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by End-User
    • 2.1.5. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Country
    • 2.1.6. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Region
  • 2.2. Competitive Insights

3. Gastroretentive Drug Delivery Systems Outsourcing Key Market Trends

  • 3.1. Gastroretentive Drug Delivery Systems Outsourcing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gastroretentive Drug Delivery Systems Outsourcing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gastroretentive Drug Delivery Systems Outsourcing Market Opportunities
  • 3.4. Gastroretentive Drug Delivery Systems Outsourcing Market Future Trends

4. Gastroretentive Drug Delivery Systems Outsourcing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gastroretentive Drug Delivery Systems Outsourcing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Gastroretentive Drug Delivery Systems Outsourcing Market Landscape

  • 6.1. Gastroretentive Drug Delivery Systems Outsourcing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gastroretentive Drug Delivery Systems Outsourcing Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
    • 7.1.2. Antidiabetics
    • 7.1.3. Antibiotics
    • 7.1.4. Proton Pump Inhibitors
    • 7.1.5. Antiemetics

8. Gastroretentive Drug Delivery Systems Outsourcing Market - By Dosage Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 8.1.2. Tablets
    • 8.1.3. Capsules
    • 8.1.4. Suspensions
    • 8.1.5. Powders

9. Gastroretentive Drug Delivery Systems Outsourcing Market - By Service Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 9.1.2. Formulation Development
    • 9.1.3. Analytical Testing
    • 9.1.4. Clinical Trials Management
    • 9.1.5. Drug Manufacturing

10. Gastroretentive Drug Delivery Systems Outsourcing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotech Companies
    • 10.1.4. CROs
    • 10.1.5. CMOs

11. Gastroretentive Drug Delivery Systems Outsourcing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Gastroretentive Drug Delivery Systems Outsourcing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Ajinomoto Bio-Pharma Services
    • 12.2.2. Alcami Corporation
    • 12.2.3. Boehringer Ingelheim International GmbH
    • 12.2.4. Catalent, Inc.
    • 12.2.5. Charles River Laboratories
    • 12.2.6. Evonik Industries AG
    • 12.2.7. Famar SA
    • 12.2.8. Jubilant Pharmova Limited
    • 12.2.9. Lonza Group AG
    • 12.2.10. Patheon N.V.
    • 12.2.11. Piramal Pharma Solutions
    • 12.2.12. Recipharm AB
    • 12.2.13. Syngene International Limited
    • 12.2.14. Thermo Fisher Scientific Inc.
    • 12.2.15. Vetter Pharma International GmbH
    • 12.2.16. WuXi AppTec Co., Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us